Hepatotoxicity of the thiazolidinediones
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 7 (2) , 369-379
- https://doi.org/10.1016/s1089-3261(03)00020-5
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The prevalence of multiple diabetes‐related complicationsDiabetic Medicine, 2000
- Improving Management of Type 2 Diabetes Mellitus: 5. ThiazolidinedionesHospital Practice, 2000
- Thiazolidinediones: a new class of antidiabetic drugsDiabetic Medicine, 1999
- Thiazolidinediones--the new insulin enhancers.Clinical and Experimental Hypertension, 1999
- Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulatorAnnals of Medicine, 1999
- Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994Diabetes Care, 1998
- Troglitazone: Review and Assessment of Its Role in the Treatment of Patients with Impaired Glucose Tolerance and Diabetes MellitusAnnals of Pharmacotherapy, 1998
- Economic Consequences of Diabetes Mellitus in the U.S. in 1997Diabetes Care, 1998
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experienceAmerican Heart Journal, 1990